Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
M01AE17	NORMODEX	G	Dexketoprofen (trometamol) - 50mg/2ml	50mg/2ml	Injectable solution	329,241 L.L
C01DA02	NITROJECT INJECTION	G	Nitroglycerine - 50mg/10ml	50mg/10ml	Injectable solution	7,018,889 L.L
M01AE02	NOPAIN DS	G	Naproxen (sodium) - 500mg	500mg	Tablet, film coated	235,172 L.L
N02BE01	NOMAL	G	Paracetamol - 500mg	500mg	Tablet	305,884 L.L
B02BD02	NOVOEIGHT	BioTech	Turoctocog Alfa - 500IU	500IU	Injectable powder for solution+diluent	29,783,973 L.L
B02BD02	NUWIQ	BioTech	Coagulation Factor VIII recombinant, human (Simoctogog alfa) - 500IU	500IU	Injectable powder for solution+diluent	47,418,699 L.L
A04AA01	NAUSETRON	G	Ondansetron - 4mg/5ml	4mg/5ml	Solution	958,608 L.L
A04AA01	NAUSETRON	G	Ondansetron - 4mg/5ml	4mg/5ml	Solution	802,466 L.L
C01CA03	NORADRENALINE HIKMA	G	Noradrenaline bitartrate - 4mg/4ml	4mg/4ml	Injectable solution	1,279,338 L.L
N04BC09	NEUPRO	B	Rotigotine - 4mg/24h	4mg/24h	Patch	7,292,823 L.L
A04AA01	NOZAMET	G	Ondansetron - 4mg	4mg	Film, orodispersible	3,234,181 L.L
L01XG03	NINLARO	B	Ixazomib - 4mg	4mg	Capsule, hard	388,991,058 L.L
C09CA07	NIZORTAN	G	Telmisartan - 40mg	40mg	Tablet	455,563 L.L
A02BC05	NEXIUM	B	Esomeprazole (magnesium trihydrate) - 40mg	40mg	Tablet, enteric coated	1,138,235 L.L
A02BC05	NEXIUM	B	Esomeprazole (magnesium trihydrate) - 40mg	40mg	Tablet, enteric coated	1,138,235 L.L
A02BC05	NEXIUM	B	Esomeprazole sodium - 40mg	40mg	Injectable powder for solution	5,254,424 L.L
A03AB06	NOSPAZM	G	Otilonium bromide - 40mg	40mg	Tablet, film coated	282,207 L.L
H02AB04	NEPHARED	G	Methylprednisolone sodium succinate - 40mg	40mg	Injectable powder for solution	188,138 L.L
J05AP08	NUCLEOBUVIR	G	Sofosbuvir - 400mg	400mg	Tablet, film coated	50,670,440 L.L
M01AE01	NORFEN 400	G	Ibuprofen - 400mg	400mg	Tablet, film coated	173,356 L.L
N03AX12	NEUROPLEX	G	Gabapentin - 400mg	400mg	Capsule	1,290,089 L.L
J01MA06	NOROXIN	B	Norfloxacin - 400mg	400mg	Tablet, film-scored	574,653 L.L
S01AE02	NAFLOX	G	Norfloxacin - 3mg/ml	3mg/ml	Drops	370,901 L.L
A04AA02	NEOSET	G	Granisetron (HCl) - 3mg/3ml	3mg/3ml	Injectable solution	405,840 L.L
L01XG03	NINLARO	B	Ixazomib - 3mg	3mg	Capsule, hard	348,420,676 L.L
H01BA02	NICTUR	G	Desmopressin acetate - 360mcg/ml	360mcg/ml	Solution	5,270,550 L.L
L03AA02	NIVESTIM	BioTech	Filgrastim - 30MIU/0.5ml	30MIU/0.5ml	Injectable solution	17,110,745 L.L
L01CA04	NAVELBINE	B	Vinorelbine (ditartrate) - 30mg	30mg	Capsule, soft gelatin	6,072,824 L.L
C08CA05	NIFELAT 30 LA	G	Nifedipine - 30mg	30mg	Tablet, prolonged release	1,007,882 L.L
C08CA06	NIMOTOP	B	Nimodipine - 30mg	30mg	Tablet, film coated	581,884 L.L